These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31970005)

  • 1. Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy.
    Othman T; Hendizadeh MS; Vankina R; Park S; Kim P
    Case Rep Oncol Med; 2020; 2020():9021843. PubMed ID: 31970005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature.
    Chatham M; Niravath P
    Cureus; 2021 Dec; 13(12):e20203. PubMed ID: 35004023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
    Le May M; Dent S
    Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review.
    Fidahussain AA; Abid A; Paracha AA; Jeevan VE; Rueve J; Engelhardt M; Schrock C; Ghani S; Nair HK
    Cureus; 2022 Nov; 14(11):e31154. PubMed ID: 36483902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report.
    Deac S; Stana MM; Havasi AD; Cainap C; Popita AR; Bordeianu AM; Cainap S; Bota M; Bochis OV
    Gynecol Oncol Rep; 2021 Feb; 35():100695. PubMed ID: 33490355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.
    Kumari VA; Gupta P; Srivastava MV; Kumar L; Kriplani A; Bhatla N
    J Obstet Gynaecol Res; 2014 May; 40(5):1463-5. PubMed ID: 24689522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.
    Venkatraman A; Opal P
    Ann Clin Transl Neurol; 2016 Aug; 3(8):655-63. PubMed ID: 27606347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Paraneoplastic Cerebellar Degeneration.
    Loehrer PA; Zieger L; Simon OJ
    Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827413
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
    Bruhnding A; Notch D; Beard A
    J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Manifesting as Acute Cerebellitis with Posterior Cranial Fossa Hypertension.
    Enríquez-Marulanda A; Beltrán-Osorio LD; Escobar LA; Granados AM; Velásquez-Lasprilla F; Orozco JL
    World Neurosurg; 2018 Apr; 112():117-122. PubMed ID: 29378343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject.
    Ng YR; Ho CD; Ng WL; Tan SM
    Surg Case Rep; 2015; 1(1):59. PubMed ID: 26366356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report.
    Cui D; Xu L; Li WY; Qian WD
    Medicine (Baltimore); 2017 Aug; 96(32):e7362. PubMed ID: 28796031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer and paraneoplastic cerebellar degeneration.
    Waterhouse DM; Natale RB; Cody RL
    Cancer; 1991 Oct; 68(8):1835-41. PubMed ID: 1913530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
    Peter E; Treilleux I; Wucher V; Jougla E; Vogrig A; Pissaloux D; Paindavoine S; Berthet J; Picard G; Rogemond V; Villard M; Vincent C; Tonon L; Viari A; Honnorat J; Dubois B; Desestret V
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35821104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
    Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
    Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.